Corey James is an Advisor in the Diabetes Complications Therapeutic Area at Eli Lilly and Company, focusing on integrating multi-omics data to identify and validate potential drug targets. Corey previously served as a Senior Principal Scientist in the Bioinformatics and Genetics Group at Lilly from 2019 to 2023 and held various application support roles at Indiana University Health and Central Indiana Orthopedics. Corey earned a Master of Science in Bioinformatics from Indiana University–Purdue University Indianapolis and a Bachelor of Applied Science in Informatics from Indiana University Bloomington.
This person is not in the org chart
This person is not in any teams
This person is not in any offices